Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulated mRNA Transport02:22

Regulated mRNA Transport

2.8K
2.8K
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

875
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
875
MicroRNAs01:22

MicroRNAs

3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
mRNA Stability and Gene Expression02:51

mRNA Stability and Gene Expression

2.8K
2.8K
Experimental RNAi02:15

Experimental RNAi

6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
Riboswitches01:56

Riboswitches

8.1K
Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
8.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dual-targeting macrophage membrane nanosystem enhances radiotherapy-induced antitumor immunity <i>via</i> synergistic nuclear and mitochondrial DNA damage.

Biomaterials science·2026
Same author

Unveiling molecular incomplete response (mIR) <i>via</i> ultra-deep NGS: a novel concept contrasting pathologic complete response (pCR) in occult lymph node micrometastases of non-small cell lung cancer.

Cancer biology & medicine·2026
Same author

From antibiotic impasse to cellular breakthrough: Advances in cell-based and cell-inspired strategies against bacterial infections.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

Elastin production by mRNA technology for rejuvenation of aged skin.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

Inhibition of protein kinase CK2 remodels the tumor immune microenvironment and sensitizes lung cancer to PD-L1 blockade.

Experimental hematology & oncology·2026
Same author

Comparative analysis of large language models and clinicians in thyroid eye disease using structured questionnaires.

Scientific reports·2026

Related Experiment Video

Updated: Jun 11, 2025

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells
10:02

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Published on: June 10, 2022

2.1K

Pharmaceutical strategies for optimized mRNA expression.

Yingying Shi1, Jiapeng Mao1, Sijie Wang1

  • 1College of Pharmaceutical Sciences, Zhejiang University, 866 Yuhangtang Road, Hangzhou, Zhejiang, 310058, PR China.

Biomaterials
|September 29, 2024
PubMed
Summary

Messenger RNA (mRNA) delivery systems are crucial for treating diseases by regulating protein levels. This review explores non-viral vector strategies to enhance mRNA stability, delivery, and therapeutic efficacy.

Keywords:
Pharmaceutical strategyStabilityTarget site accumulationTransfection efficiencymRNA

More Related Videos

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
08:29

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

10.0K
In Vitro Synthesis of Modified mRNA for Induction of Protein Expression in Human Cells
10:07

In Vitro Synthesis of Modified mRNA for Induction of Protein Expression in Human Cells

Published on: November 13, 2014

24.9K

Related Experiment Videos

Last Updated: Jun 11, 2025

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells
10:02

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Published on: June 10, 2022

2.1K
Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
08:29

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

10.0K
In Vitro Synthesis of Modified mRNA for Induction of Protein Expression in Human Cells
10:07

In Vitro Synthesis of Modified mRNA for Induction of Protein Expression in Human Cells

Published on: November 13, 2014

24.9K

Area of Science:

  • Biotechnology and Pharmaceutical Sciences
  • Molecular Medicine
  • Drug Delivery Systems

Background:

  • Messenger RNA (mRNA) therapeutics offer potential for treating diseases linked to aberrant protein levels.
  • Effective delivery of mRNA to target cells is essential for therapeutic success.
  • Non-viral vectors are key pharmaceutical strategies for safe and stable mRNA delivery.

Purpose of the Study:

  • To review existing mRNA delivery systems from a pharmaceutical viewpoint.
  • To analyze the impact of formulation and preparation techniques on non-viral vectors.
  • To explore strategies for combining mRNA with small molecules for enhanced therapeutic outcomes.

Main Methods:

  • Review of current literature on mRNA delivery systems.
  • Analysis of formulation adjustments and preparation techniques for non-viral vectors.
  • Examination of synergistic strategies combining mRNA and small molecules.

Main Results:

  • Formulation and preparation significantly impact mRNA stability, target accumulation, and transfection efficiency.
  • Non-viral vectors present diverse structural characteristics and modes of action.
  • Combination strategies can augment mRNA potency and mitigate adverse effects.

Conclusions:

  • Optimizing non-viral vector delivery is critical for advancing mRNA therapeutics.
  • Further research into synergistic combinations holds promise for improved efficacy and safety.
  • Addressing challenges in mRNA drug development will unlock future therapeutic advancements.